Document Type
Journal Article
Publication Title
Engineering
Publisher
Elsevier
School
Centre for Precision Health
RAS ID
53023
Funders
This study was funded by National Natural Science Foundation of China (8177120753) and China–Australia International Collaborative Grant (NHMRC APP1112767, NSFC 81561128020) to Wei Wang. Zhiyuan Wu was supported by the China Scholarship Council (201908110447). Yulu Zheng and Zheng Guo were supported by the Edith Cowan University Higher Degree by Research Scholarship (ECU-HDR ST10469322 and ST10468211).
Grant Number
NHMRC Number : APP1112768
Abstract
The use of an altered immunoglobulin G (IgG) N-glycan pattern as an inflammation metric has been reported in subclinical atherosclerosis and metabolic disorders, both of which are important risk factors in cardiovascular health. However, the usable capacity of IgG N-glycosylation profiles for the risk stratification of cardiovascular diseases (CVDs) remains unknown. This study aimed to develop a cardiovascular aging index for tracking cardiovascular risk using IgG N-glycans. This cross-sectional investigation enrolled 1465 individuals aged 40–70 years from the Busselton Healthy and Ageing Study. We stepwise selected the intersection of altered N-glycans using feature-selection methods in machine learning (recursive feature elimination and penalized regression algorithms) and developed an IgG N-glycosylation cardiovascular age (GlyCage) index to reflect the deviation from calendar age attributable to cardiovascular risk. The strongest contributors to GlyCage index were fucosylated N-glycans with bisecting N-acetylglucosamine (GlcNAc) (glycan peak 6 (GP6), FA2B,) and digalactosylated N-glycans with bisecting GlcNAc (GP13, A2BG2). A one-unit increase of GlyCage was significantly associated with a higher Framingham ten-year cardiovascular risk (odds ratio (OR), 1.09; 95% confidence interval (95% CI): 1.05–1.13) and probability of CVDs (OR, 1.07; 95% CI: 1.01–1.13) independent of calendar age. Individuals with excessive GlyCage (exceeding a calendar age > 3 years) had an increased cardiovascular risk and probability of CVDs, with adjusted ORs of 2.22 (95% CI: 1.41–3.53) and 2.71 (95% CI: 1.25–6.41), respectively. The area under curve (AUC) values of discriminating high cardiovascular risk and events were 0.73 and 0.65 for GlyCage index, and 0.65 and 0.63 for calendar age. The GlyCage index developed in this study can thus be used to track cardiovascular health using IgG N-glycosylation profiles. The distance between GlyCage and calendar age independently indicates the cardiovascular risk, suggesting that IgG N-glycosylation plays a role in the pathogenesis of CVDs. The generalization of the observed associations and the predictive capability of GlyCage index require external and longitudinal validation in other populations.
DOI
10.1016/j.eng.2022.12.004
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.
Comments
Wu, Z., Guo, Z., Zheng, Y., Wang, Y., Zhang, H., Pan, H., ... & Wang, W. (2023). IgG N-glycosylation cardiovascular age tracks cardiovascular risk beyond calendar age. Engineering, 26, 99-107. https://doi.org/10.1016/j.eng.2022.12.004